Sponsor Pipeline

Qian Chu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
3
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06001151 Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small… Carcinoma, Non-Small-Cell Lung Recruiting
NCT04888429 Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary… Sarcomatoid Carcinoma of Lung Recruiting
NCT07055581 Durvalumab as Consolidation for Patients LS-SCLC Small Cell Lung Cancer Limited Stage Recruiting
Not specified
NCT07131670 Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights… Lung Cancer Recruiting
NCT07388771 Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC） NSCLC Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Sarcoma (1) Small Cell Lung Cancer (1)
Get alerts when Qian Chu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free